Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.
about
How Effective Are Percutaneous Liver-Directed Therapies in Patients with Non-Colorectal Liver Metastases?Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacyRadiofrequency heat-enhanced chemotherapy for breast cancer: towards interventional molecular image-guided chemotherapyEfficient electroporation of liposomes doped with pore stabilizing nisin.Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.Radiofrequency ablation-induced upregulation of hypoxia-inducible factor-1α can be suppressed with adjuvant bortezomib or liposomal chemotherapy.Systematic review of ablation techniques for the treatment of malignant or aggressive benign lesions in children.DDMC-p53 gene therapy with or without cisplatin and microwave ablation.Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy.Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines.Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes.Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculature.Computational modelling of microwave tumour ablationsIntratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-diethylaminoethyl-dextran methyl methacrylate copolymer non-viral vector-p53.Magnetic Resonance-Guided Drug Delivery.Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.Lung radiofrequency ablation: potential as a therapy to oligometastasis and oligorecurrence.Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment.New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity.Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
P2860
Q26764993-FB4D6965-5DE1-4D6F-BF9F-1EC005F21604Q28542027-7D59A469-B55A-428A-A02F-C68CA8C66D24Q34195652-6E156327-E02B-43D7-B97E-DEC747760ACDQ34675279-7EDEDFE4-1F17-452B-9EFD-E3EEC847591FQ34680997-CC4EA486-39B1-48BA-94A7-101D9156285EQ34725980-989D0A42-A653-46CE-B2C8-18F5A44503E8Q35167550-07E7EC3A-35A6-43B0-9D14-DEEA03C686CBQ35654976-6B7D3227-3323-462E-913F-6E1475783D56Q35831738-D1194FE4-8650-4D2E-BA8A-98F481A91449Q36390438-6DDE8880-D5F1-4E03-AACE-EA21E3F7505DQ36392418-1EC4581C-28C5-4240-9735-4683F9CA2E42Q37033793-F034CCDF-2691-47ED-A9B2-2EF77BD84A50Q37083651-ACD65D98-0D20-4CBB-BDEB-8B6CE54ECF76Q37196965-8925C567-ACDD-449E-8ABA-7D6C36F11FACQ38112178-7D61725B-CCD8-4B48-A80A-90DD8CBD611AQ38451785-E1DDF8BC-9768-49E8-8F80-0E3AA03F3573Q38616007-A27F5DAB-56D6-489F-8341-5054ACAE57FEQ38776676-B171E95A-6503-4C42-9EC9-C2174DE1783CQ39525564-00F9DAB2-C55C-4C83-81CF-0F1CA3888F06Q45871652-B001BDCF-60F0-4E2D-9D24-7A4945DEE1B9Q47375034-4AE47472-05B4-4786-ABD6-1E400EB7B547Q48314799-F9EFC61B-B735-437E-A71B-BA18107039D4Q51731998-68E1ED6C-FA66-42FB-8B84-C267FEB9D4C1
P2860
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.
@en
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.
@nl
type
label
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.
@en
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.
@nl
prefLabel
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.
@en
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.
@nl
P2093
P2860
P1476
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.
@en
P2093
Marwan Moussa
Muneeb Ahmed
S Nahum Goldberg
P2860
P304
P356
10.1016/J.CHEMPHYSLIP.2011.12.002
P577
2011-12-14T00:00:00Z